Didanosine associated with non-cirrhotic portal HTN
Physicians who care for HIV patients should be aware of a safety warning of the association between the HIV drug didanosine and non-cirrhotic portal HTN with esophageal varices. There have been 42 reported cases and 4 deaths (FDA site)
